Get notified when VNRX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Covenant Violation (new) — Company violated minimum market capitalization covenant on convertible debt, requiring lender waiver to avoid acceleration.
VolitionRx breaches debt covenant, faces $990K penalty and more dilutive conversion terms
Filed May 22, 2026 · Period ending May 21, 2026 · ~1 min read
Key Changes
-
high
Company violated minimum market capitalization requirement on $9.9M in convertible notes, triggering automatic 10% penalty ($990K) on outstanding principal and requiring lender waiver to avoid immediate repayment.
Item 1.01 verify on EDGAR → -
high
Lender Lind can now convert debt to shares at more favorable terms: the lower of existing conversion price or 90% of the average of three lowest trading prices over prior 20 days, significantly increasing dilution risk.
Item 1.01 verify on EDGAR → -
high
Waiver prevents immediate default and acceleration of $9.9M debt ($7.5M from May 2025 note, $2.4M from January 2026 note), but company's declining market cap suggests ongoing covenant compliance challenges.
Item 1.01 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.
Partner
Trade VNRX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · May 24, 2026 · How we verify